GLASSIA

Google image searchProduct monograph

Active ingredient

alpha1-proteinase inhibitor (human), 1000 MG/50 ML

DIN: 02522438

Dosage form(s): SOLUTION

Route(s) of administration: INTRAVENOUS

Description: SINGLE USE VIAL

Schedule: Schedule D

Company: TAKEDA CANADA INC

Date: 02-JAN-2024

ATC:

• B02 — ANTIHEMORRHAGICS (ATC, ATC/DDD, )
• B02A — ANTIFIBRINOLYTICS (ATC, ATC/DDD)
• B02AB — Proteinase inhibitors (ATC, ATC/DDD)
• B02AB02 — ALFA1 ANTITRYPSIN (ATC/DDD)

Reference brand drug: Prolastin, Glassia

External Links for Glassia

Search on Google

• Glassia side effects
• Glassia dosage
• alpha1-proteinase inhibitor side effects
• alpha1-proteinase inhibitor dosage

Takeda Canada Inc

Go to Takeda website to see drug product details. Sometimes you can find glassia photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.